3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Breast Neoplasms
33
Neoplasms
25
Prostatic Neoplasms
16
Colorectal Neoplasms
13
Lung Neoplasms
11
Multiple Myeloma
9
Head and Neck Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Hematologic Neoplasms
5
Gastrointestinal Neoplasms
5
Advanced Cancer
5
Uterine Cervical Neoplasms
4
Smoking Cessation
4
Ovarian Neoplasms
4
Melanoma
4
Leukemia
4
Colonic Neoplasms
4
Anxiety Disorders
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Neoplasms, Plasma Cell
3
Motor Activity
3
Lymphoma, Follicular
3
Lymphedema
3
Interventions
Trastuzumab
25
Paclitaxel
22
Cyclophosphamide
20
Docetaxel
17
Taxes
14
Lapatinib
13
Doxorubicin
13
Radiotherapy
12
Bevacizumab
11
Capecitabine
10
Tamoxifen
9
Immunohistochemistry
9
sargramostim
8
Granulocyte-Macrophage Colony-Stimulating Factor
8
Filgrastim
8
Carboplatin
8
Vorinostat
6
Magnetic Resonance Spectroscopy
6
Erlotinib Hydrochloride
6
Chemotherapy, Adjuvant
6
Biopsy
6
Peripheral Blood Stem Cell Transplantation
5
Everolimus
5
liposomal doxorubicin
4
ixabepilone
4
Vinorelbine
4
Neoadjuvant Therapy
4
Immunoenzyme Techniques
4
Gene Expression Profiling
4
Fluorodeoxyglucose F18
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Breast Neoplasms, Male
×
Standard of Care
×
Clear all
NCT02957981
2023-09-13
GEM
Georgetown University
Phase NA
Completed
63 enrolled